Evgeniy A. Tarabrin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Evgeniy A. Tarabrin has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
- Zelimkhan G. Berikkhanov
Department of Hospital Surgery No. 2, Sechenov First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia
29 shared publications - Milena Yu. Ivanova
Department of Hospital Surgery No. 2, Sechenov First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia
22 shared publications - Sergey Yurievich Muraviev
Department of Hospital Surgery No. 2, Sechenov First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia
20 shared publications - Alexey L. Shestakov
Department of Hospital Surgery No. 2, Sechenov First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia
15 shared publications - Andrey M. Nikolaev
Department of Hospital Surgery No. 2, Sechenov First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia
14 shared publications - Vadim Sergeevich Razumovsky
Department of Hospital Surgery No. 2, Sechenov First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia
14 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by MDPI AG in Pathophysiology
- Vol. 33 (4) , 86
Posterior Mediastinal Müllerian Cyst (Hattori’s Cyst): A Case Report and Review of Pathogenesis and Diagnostic Features
Background: Posterior mediastinal Müllerian cysts are radiologically nonspecific lesions whose tubal-type epithelium raises unresolved questions about tissue origin. We describe a symptomatic case and review the published evidence. Case Presentation: A 44-year-old woman had recurrent right-sided chest pain for 4 years. Computed tomography showed an 18 × 26 × 32 mm paravertebral cyst at T5–T7 with an attenuation of 8 Hounsfield units. Magnetic resonance imaging excluded spinal involvement. Video-assisted thoracoscopic excision was followed by uncomplicated recovery. Ciliated epithelium with paired box protein 8 (PAX8), estrogen receptor, and progesterone receptor expression supported Müllerian differentiation. At 11 months, chest pain had resolved and usual activities had resumed. Literature Review: A narrative review with a structured search included 61 previously published patients in 45 publications. The combined sample, including the present case, comprised 62 patients, of whom 60 were women and 2 were men. Thirty-six patients (58.1%) were asymptomatic. Proposed origins include developmental persistence, coelomic metaplasia, and vascular or lymphatic dissemination. None has been demonstrated directly. Reported follow-up was heterogeneous and does not support a reliable estimate of recurrence. Conclusions: Imaging defines location and cystic structure but cannot establish Müllerian differentiation. Diagnosis requires concordant morphology and immunohistochemistry, irrespective of patient sex. Minimally invasive excision can provide diagnosis and symptom relief when symptoms or diagnostic uncertainty justify intervention.
- 13 November 2026
- Published by MDPI AG in Pathophysiology
- Vol. 33 (4) , 86
Open AccessPosterior Mediastinal Müllerian Cyst (Hattori’s Cyst): A Case Report and Review of Pathogenesis and Diagnostic Features
Background: Posterior mediastinal Müllerian cysts are radiologically nonspecific lesions whose tubal-type epithelium raises unresolved questions about tissue origin. We describe a symptomatic case and review the published evidence. Case Presentation: A 44-year-old woman had recurrent right-sided chest pain for 4 years. Computed tomography showed an 18 × 26 × 32 mm paravertebral cyst at T5–T7 with an attenuation of 8 Hounsfield units. Magnetic resonance imaging excluded spinal involvement. Video-assisted thoracoscopic excision was followed by uncomplicated recovery. Ciliated epithelium with paired box protein 8 (PAX8), estrogen receptor, and progesterone receptor expression supported Müllerian differentiation. At 11 months, chest pain had resolved and usual activities had resumed. Literature Review: A narrative review with a structured search included 61 previously published patients in 45 publications. The combined sample, including the present case, comprised 62 patients, of whom 60 were women and 2 were men. Thirty-six patients (58.1%) were asymptomatic. Proposed origins include developmental persistence, coelomic metaplasia, and vascular or lymphatic dissemination. None has been demonstrated directly. Reported follow-up was heterogeneous and does not support a reliable estimate of recurrence. Conclusions: Imaging defines location and cystic structure but cannot establish Müllerian differentiation. Diagnosis requires concordant morphology and immunohistochemistry, irrespective of patient sex. Minimally invasive excision can provide diagnosis and symptom relief when symptoms or diagnostic uncertainty justify intervention.
- Open Access
- 5 November 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 185 (4) , 99-107
Prolonged air leakage after lung resection
The OBJECTIVE was to present mechanisms, risk factors, prevention methods, and treatment of air leakage after lung resection surgeries based on the analysis of literature sources.METHODS AND MATERIALS. Sources from the international databases Scopus, PubMed, Google Scholar as well as the national library system eLibrary were used for literature analysis.CONCLUSION. Air leakage is a frequent postoperative complication of lung operations and the main factor affecting the duration of pleural cavity drainage, which can lead to the development of complications. There is still no consensus on the methods of prevention and treatment of this category of patients. Further research will make it possible to develop combined approaches to prevention and treatment adapted for each patient.
- 5 November 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 185 (4) , 99-107
Open AccessProlonged air leakage after lung resection
The OBJECTIVE was to present mechanisms, risk factors, prevention methods, and treatment of air leakage after lung resection surgeries based on the analysis of literature sources.METHODS AND MATERIALS. Sources from the international databases Scopus, PubMed, Google Scholar as well as the national library system eLibrary were used for literature analysis.CONCLUSION. Air leakage is a frequent postoperative complication of lung operations and the main factor affecting the duration of pleural cavity drainage, which can lead to the development of complications. There is still no consensus on the methods of prevention and treatment of this category of patients. Further research will make it possible to develop combined approaches to prevention and treatment adapted for each patient.
- Open Access
- 5 November 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 185 (4) , 45-51
Systemic embolization in oncological patients with pulmonary bleeding
The OBJECTIVE was to evaluate the effectiveness and safety of systemic embolization in cancer patients with pulmonary bleeding.METHODS AND MATERIALS. A retrospective single-center study of medical records of patients treated at the Ryazan Regional Clinical Hospital in the period 2020–2022 was conducted. The inclusion criteria were patients over 18 years of age with a breast cancer complicated by PB who underwent bronchial angiography. A total of 65 patients were selected. The PB signs during contrast enhancement of systemic vessels were divided into direct and indirect. After identifying the pathology of systemic vessels, they were embolized. The study evaluated the hospital-based effectiveness of hemostasis (immediate clinical success), the technical success of endovascular treatment, late clinical success (no recurrence of PB within a month), early (within a month) and late PB recurrences (more than a month), postoperative complications, and postoperative mortality.RESULTS. In our study, the sensitivity of the X-ray endovascular method in cancer patients with PB was 87.7 %. Bronchial arteriography was completed by embolization of the affected vessels in 53 cases during the primary X-ray endovascular examination and in 3 cases during the repeated examination. Thus, the technical success rate was 86.2 %. The immediate clinical success rate was 100 %. The late clinical success rate was 92.4 %. The rate of early recurrences (within a month) of PB in cancer patients did not exceed 7.5 %. Of the 50 cancer patients who underwent systemic embolization for PB, two patients (3.8 %) had PB recurrence within a year due to bronchial artery revascularization. Hyperthermia was a common postoperative symptom after systemic embolization in 25 (47.2 %) patients. In two (3.8 %) patients, the treatment was complicated by bronchial destruction and hemorrhagic stroke, which accounted for the 3.8 % mortality rate.CONCLUSIONS. Systemic embolization is the effective and safe method of treatment of pulmonary bleeding in cancer patients. This method has a high technical and clinical success and, due to the improvement of endovascular techniques, minimizes postoperative complications and lethality.
- 5 November 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 185 (4) , 45-51
Open AccessSystemic embolization in oncological patients with pulmonary bleeding
The OBJECTIVE was to evaluate the effectiveness and safety of systemic embolization in cancer patients with pulmonary bleeding.METHODS AND MATERIALS. A retrospective single-center study of medical records of patients treated at the Ryazan Regional Clinical Hospital in the period 2020–2022 was conducted. The inclusion criteria were patients over 18 years of age with a breast cancer complicated by PB who underwent bronchial angiography. A total of 65 patients were selected. The PB signs during contrast enhancement of systemic vessels were divided into direct and indirect. After identifying the pathology of systemic vessels, they were embolized. The study evaluated the hospital-based effectiveness of hemostasis (immediate clinical success), the technical success of endovascular treatment, late clinical success (no recurrence of PB within a month), early (within a month) and late PB recurrences (more than a month), postoperative complications, and postoperative mortality.RESULTS. In our study, the sensitivity of the X-ray endovascular method in cancer patients with PB was 87.7 %. Bronchial arteriography was completed by embolization of the affected vessels in 53 cases during the primary X-ray endovascular examination and in 3 cases during the repeated examination. Thus, the technical success rate was 86.2 %. The immediate clinical success rate was 100 %. The late clinical success rate was 92.4 %. The rate of early recurrences (within a month) of PB in cancer patients did not exceed 7.5 %. Of the 50 cancer patients who underwent systemic embolization for PB, two patients (3.8 %) had PB recurrence within a year due to bronchial artery revascularization. Hyperthermia was a common postoperative symptom after systemic embolization in 25 (47.2 %) patients. In two (3.8 %) patients, the treatment was complicated by bronchial destruction and hemorrhagic stroke, which accounted for the 3.8 % mortality rate.CONCLUSIONS. Systemic embolization is the effective and safe method of treatment of pulmonary bleeding in cancer patients. This method has a high technical and clinical success and, due to the improvement of endovascular techniques, minimizes postoperative complications and lethality.
- Open Access
- 15 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3360
Biomarkers in Acute Mesenteric Ischemia: A Systematic Review of Diagnostic Performance and Injury-Related Signals
Background/Objectives: We examined nine biomarkers for acute mesenteric ischemia (AMI) detection, necrosis and postoperative prediction. Methods: PubMed/MEDLINE, the Cochrane Library and indexed citation links were searched on 10 October 2026 without a lower publication-year limit. PubMed and citation searches used an October 2026 publication cutoff. English- and Russian-language clinical reports with at least 10 participants were eligible. Narrative synthesis used QUADAS-2 and diagnostic GRADE. Results: Twenty-nine primary reports were included, with reported cohorts of 18–1479 participants. Cohort overlap and varying tested denominators precluded an unduplicated participant total. Among 28 diagnostic reports, 22 had high index-test risk and 25 had high flow/timing risk. Certainty was very low for eight markers. I-FABP, α-GST and citrulline findings depended on population, assay and timing. D-dimer, lactate, procalcitonin and ischemia-modified albumin lacked intestinal specificity. Urinary I-FABP estimates were imprecise. SM22 supplied association data without diagnostic-performance estimates. Conclusions: No evaluated marker supports reliable stand-alone exclusion of AMI or determination of bowel viability. Complementary panels require prospective validation. The injury diagrams are unvalidated research models.
- 15 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3360
Open AccessBiomarkers in Acute Mesenteric Ischemia: A Systematic Review of Diagnostic Performance and Injury-Related Signals
Background/Objectives: We examined nine biomarkers for acute mesenteric ischemia (AMI) detection, necrosis and postoperative prediction. Methods: PubMed/MEDLINE, the Cochrane Library and indexed citation links were searched on 10 October 2026 without a lower publication-year limit. PubMed and citation searches used an October 2026 publication cutoff. English- and Russian-language clinical reports with at least 10 participants were eligible. Narrative synthesis used QUADAS-2 and diagnostic GRADE. Results: Twenty-nine primary reports were included, with reported cohorts of 18–1479 participants. Cohort overlap and varying tested denominators precluded an unduplicated participant total. Among 28 diagnostic reports, 22 had high index-test risk and 25 had high flow/timing risk. Certainty was very low for eight markers. I-FABP, α-GST and citrulline findings depended on population, assay and timing. D-dimer, lactate, procalcitonin and ischemia-modified albumin lacked intestinal specificity. Urinary I-FABP estimates were imprecise. SM22 supplied association data without diagnostic-performance estimates. Conclusions: No evaluated marker supports reliable stand-alone exclusion of AMI or determination of bowel viability. Complementary panels require prospective validation. The injury diagrams are unvalidated research models.
- Open Access
- 8 October 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (5) , 841-851
Lung volume reduction surgery for emphysema
Chronic obstructive pulmonary disease (COPD) is a widespread disease that often leads to disability and death. Pulmonary emphysema (PE), a morphological component of COPD, causes hyperinflation, disturbances in the ventilationperfusion ratio, and progressive respiratory insufficiency. The ineffectiveness of conservative therapy determines the need to find surgical treatment strategies. Lung volume reduction surgery in patients with severe emphysema is aimed at removing the least functional part of the lungs to improve airflow, diaphragm and chest wall mechanics, as well as alveolar gas exchange. Aim. The aim of the review is to systematize data on surgical reduction of lung volume to improve severe PE, taking into account current complex treatment of COPD and PE based on an analysis of global and domestic literature. Methods . Sources from the international databases Scopus, PubMed, Google Scholar as well as the domestic system eLibrary were used for literature analysis. Conclusion. Modern technologies allow extending the traditional criteria of emphysema surgery, including bronchological methods. Indications for intervention are now considered for both severe and early stages of the disease, including homogenous form, in order to slow its progression. Early diagnosis and multidisciplinary selection of patients plays a key role. Of particular interest is the treatment of young patients to maintain their activity.
- 8 October 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (5) , 841-851
Open AccessLung volume reduction surgery for emphysema
Chronic obstructive pulmonary disease (COPD) is a widespread disease that often leads to disability and death. Pulmonary emphysema (PE), a morphological component of COPD, causes hyperinflation, disturbances in the ventilationperfusion ratio, and progressive respiratory insufficiency. The ineffectiveness of conservative therapy determines the need to find surgical treatment strategies. Lung volume reduction surgery in patients with severe emphysema is aimed at removing the least functional part of the lungs to improve airflow, diaphragm and chest wall mechanics, as well as alveolar gas exchange. Aim. The aim of the review is to systematize data on surgical reduction of lung volume to improve severe PE, taking into account current complex treatment of COPD and PE based on an analysis of global and domestic literature. Methods . Sources from the international databases Scopus, PubMed, Google Scholar as well as the domestic system eLibrary were used for literature analysis. Conclusion. Modern technologies allow extending the traditional criteria of emphysema surgery, including bronchological methods. Indications for intervention are now considered for both severe and early stages of the disease, including homogenous form, in order to slow its progression. Early diagnosis and multidisciplinary selection of patients plays a key role. Of particular interest is the treatment of young patients to maintain their activity.
- Open Access
Viral Signals in Acute Appendicitis: Direct Tissue Infection, Systemic Triggers, and the Unresolved Biology of Spontaneous Resolution
Background/Objectives: Acute appendicitis is readily recognised, but its initiating mechanisms remain uncertain. Viral findings are often interpreted without separating direct appendiceal infection, systemic host responses, clinical phenocopies, and virome effects. We examined the evidence for these scenarios and their possible relationship to spontaneous resolution. Methods: A structured narrative synthesis of 82 publications integrated tissue studies, clinical series, epidemiology, microbiome and virome research, natural history, and treatment outcomes. Results: Direct viral injury is documented in rare clinicopathological settings. Available tissue studies argue against frequent direct adenoviral infection. Systemic infection could provoke lymphoid activation, oedema, or early microvascular injury, but this causal sequence has not been demonstrated in humans. Clinical studies document resolution in selected uncomplicated cases, including recovery without antibiotics, without establishing a viral cause. Conclusions: The framework separates observed findings from competing causal hypotheses. A viral prodrome is a candidate research variable whose independent diagnostic and prognostic value remains unestablished. Prospective studies must link infection chronology to local inflammation and subsequent outcomes before such information can guide treatment. Viral symptoms or positive tests cannot justify withholding indicated antibiotics or surgery.
Open AccessViral Signals in Acute Appendicitis: Direct Tissue Infection, Systemic Triggers, and the Unresolved Biology of Spontaneous Resolution
Background/Objectives: Acute appendicitis is readily recognised, but its initiating mechanisms remain uncertain. Viral findings are often interpreted without separating direct appendiceal infection, systemic host responses, clinical phenocopies, and virome effects. We examined the evidence for these scenarios and their possible relationship to spontaneous resolution. Methods: A structured narrative synthesis of 82 publications integrated tissue studies, clinical series, epidemiology, microbiome and virome research, natural history, and treatment outcomes. Results: Direct viral injury is documented in rare clinicopathological settings. Available tissue studies argue against frequent direct adenoviral infection. Systemic infection could provoke lymphoid activation, oedema, or early microvascular injury, but this causal sequence has not been demonstrated in humans. Clinical studies document resolution in selected uncomplicated cases, including recovery without antibiotics, without establishing a viral cause. Conclusions: The framework separates observed findings from competing causal hypotheses. A viral prodrome is a candidate research variable whose independent diagnostic and prognostic value remains unestablished. Prospective studies must link infection chronology to local inflammation and subsequent outcomes before such information can guide treatment. Viral symptoms or positive tests cannot justify withholding indicated antibiotics or surgery.
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in I.P. Pavlov Russian Medical Biological Herald
- Vol. 34 (3) , 315-324
Comparative evaluation of methods of hemostasis in oncology patients with pulmonary hemorrhage
BACKGROUND: Pulmonary hemorrhage (PH) is a serious, often fatal, complication of thoracic malignancies. Fatal outcomes from PH in most cases result not from blood loss, but from obstruction of the tracheobronchial tree, leading to asphyxia. Currently, there is no unified diagnostic and treatment algorithm for patients with PH. Some authors are proponents of pharmacological therapy, while others support surgical intervention. Search for effective and safe treatment for PH in cancer patients is a pressing issue. AIM: To compare the efficacy and safety of medical, endovascular, and surgical treatments for pulmonary hemorrhage in patients with lung tumors. METHODS: From 2010 to 2022, 258 cancer patients with PH underwent treatment. Depending on the therapeutic approach, patients were divided into three groups: Group 1 (medical therapy, n=196), Group 2 (endovascular intervention, n=53), Group 3 (surgical treatment, n=39). Comparison parameters: in-hospital success rate, 30-day PH recurrence rate, hospital length of stay (LOS), postoperative complications, and mortality. RESULTS: Medical therapy in cancer patients complicated by PH, demonstrated the lowest result in terms of in-hospital success rate (77.0%), 30-day recurrence rate (52.0%) and a possibility for subsequent specialized antitumor treatment (21.4%). Endovascular and surgical treatments demonstrated high in-hospital success rate (100%) and the lowest 30-day recurrence rate. CONCLUSION: Medical therapy in cancer patients with PH yields the lowest results in the above criteria. Endovascular method in inoperable cancer patients with PH provides stable hemostasis with a favorable safety profile, enabling most patients to proceed with antitumor treatment.
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in I.P. Pavlov Russian Medical Biological Herald
- Vol. 34 (3) , 315-324
Comparative evaluation of methods of hemostasis in oncology patients with pulmonary hemorrhage
BACKGROUND: Pulmonary hemorrhage (PH) is a serious, often fatal, complication of thoracic malignancies. Fatal outcomes from PH in most cases result not from blood loss, but from obstruction of the tracheobronchial tree, leading to asphyxia. Currently, there is no unified diagnostic and treatment algorithm for patients with PH. Some authors are proponents of pharmacological therapy, while others support surgical intervention. Search for effective and safe treatment for PH in cancer patients is a pressing issue. AIM: To compare the efficacy and safety of medical, endovascular, and surgical treatments for pulmonary hemorrhage in patients with lung tumors. METHODS: From 2010 to 2022, 258 cancer patients with PH underwent treatment. Depending on the therapeutic approach, patients were divided into three groups: Group 1 (medical therapy, n=196), Group 2 (endovascular intervention, n=53), Group 3 (surgical treatment, n=39). Comparison parameters: in-hospital success rate, 30-day PH recurrence rate, hospital length of stay (LOS), postoperative complications, and mortality. RESULTS: Medical therapy in cancer patients complicated by PH, demonstrated the lowest result in terms of in-hospital success rate (77.0%), 30-day recurrence rate (52.0%) and a possibility for subsequent specialized antitumor treatment (21.4%). Endovascular and surgical treatments demonstrated high in-hospital success rate (100%) and the lowest 30-day recurrence rate. CONCLUSION: Medical therapy in cancer patients with PH yields the lowest results in the above criteria. Endovascular method in inoperable cancer patients with PH provides stable hemostasis with a favorable safety profile, enabling most patients to proceed with antitumor treatment.
- Open Access
From Bile Dysmetabolism to Lipid–Metabolic Remodeling of the Distal Colon: A Vectorial Concept of Colorectal Carcinogenesis (Part I)
Colorectal cancer (CRC) is traditionally viewed as the result of the sequential accumulation of molecular alterations and the clonal expansion of transformed cells. However, the state of morphologically non-neoplastic mucosa preceding the development of neoplasia remains considerably less well characterized. This narrative review aims to integrate evidence on biliary and lipid metabolism, intestinal transit, microbial metabolism, and field cancerization and to formulate a testable model of early metabolic remodeling in the distal colon. We propose that a chronically altered biliary–metabolic environment, combined with prolonged luminal and mucosa-associated exposure, may promote lipid–metabolic remodeling of morphologically non-neoplastic mucosa. This state is considered not as a new disease entity but as a potential tissue phenotype capable of altering the barrier, metabolic, and regenerative properties of the epithelium. Subsequent exposure to nitrogen-containing products of microbial metabolism may sustain repeated cycles of injury and regeneration, thereby creating conditions for clonal selection. Following the emergence of a neoplastic clone, the same local environment may potentially assume a different biological role and become part of a metabolic niche that supports further clonal expansion. The proposed model extends the concept of field cancerization by incorporating a metabolic dimension and generates a series of spatial and temporal predictions amenable to experimental and prospective clinical testing. Validation of this model may provide a basis for investigating morphologically non-neoplastic mucosa as potential tissue at risk and for developing earlier preventive and diagnostic approaches.
Open AccessFrom Bile Dysmetabolism to Lipid–Metabolic Remodeling of the Distal Colon: A Vectorial Concept of Colorectal Carcinogenesis (Part I)
Colorectal cancer (CRC) is traditionally viewed as the result of the sequential accumulation of molecular alterations and the clonal expansion of transformed cells. However, the state of morphologically non-neoplastic mucosa preceding the development of neoplasia remains considerably less well characterized. This narrative review aims to integrate evidence on biliary and lipid metabolism, intestinal transit, microbial metabolism, and field cancerization and to formulate a testable model of early metabolic remodeling in the distal colon. We propose that a chronically altered biliary–metabolic environment, combined with prolonged luminal and mucosa-associated exposure, may promote lipid–metabolic remodeling of morphologically non-neoplastic mucosa. This state is considered not as a new disease entity but as a potential tissue phenotype capable of altering the barrier, metabolic, and regenerative properties of the epithelium. Subsequent exposure to nitrogen-containing products of microbial metabolism may sustain repeated cycles of injury and regeneration, thereby creating conditions for clonal selection. Following the emergence of a neoplastic clone, the same local environment may potentially assume a different biological role and become part of a metabolic niche that supports further clonal expansion. The proposed model extends the concept of field cancerization by incorporating a metabolic dimension and generates a series of spatial and temporal predictions amenable to experimental and prospective clinical testing. Validation of this model may provide a basis for investigating morphologically non-neoplastic mucosa as potential tissue at risk and for developing earlier preventive and diagnostic approaches.
- Open Access
- 28 September 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (10) , 721
Bile Biochemistry as a Therapeutic Target in Biliary Surgery: Disease-Specific Evidence and Clinical Limits
Background/Objectives: Bile acid therapies have expanded treatment options for cholestatic disease, but their relevance to biliary surgery depends on the diagnosis and endpoint. This critical narrative review examines where molecular evidence changes care and where surgical applications remain untested. Methods: The existing synthesis was supplemented by targeted literature searches and regulatory checks completed on 20 September 2026. Studies were assessed by design, population, outcome, and applicability to surgical decisions. Results: Genetic assessment can identify inherited cholestasis or selected recurrent lithogenic disorders that persist after anatomical treatment. Evidence for ileal bile acid transporter inhibitors supports indication-specific relief of cholestatic pruritus. Recent trials of receptor agonists show that biochemical, symptomatic, and disease-progression outcomes can diverge. Observational studies support biliary diversion in selected patients with inherited cholestasis, although comparisons among procedures and with drug treatment remain uncertain. The expanding genetic spectrum of progressive familial intrahepatic cholestasis and real-world treatment reports refine patient selection but provide limited evidence for long-term surgical outcomes. Bile metabolomics and synthesis markers remain unvalidated for timing cholecystectomy. Conclusions: Molecular findings are useful when they answer a defined diagnostic or therapeutic question. They can guide specialist treatment and surveillance alongside anatomical assessment. Prospective studies must establish whether molecular stratification improves outcomes in biliary surgical populations.
- 28 September 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (10) , 721
Open AccessBile Biochemistry as a Therapeutic Target in Biliary Surgery: Disease-Specific Evidence and Clinical Limits
Background/Objectives: Bile acid therapies have expanded treatment options for cholestatic disease, but their relevance to biliary surgery depends on the diagnosis and endpoint. This critical narrative review examines where molecular evidence changes care and where surgical applications remain untested. Methods: The existing synthesis was supplemented by targeted literature searches and regulatory checks completed on 20 September 2026. Studies were assessed by design, population, outcome, and applicability to surgical decisions. Results: Genetic assessment can identify inherited cholestasis or selected recurrent lithogenic disorders that persist after anatomical treatment. Evidence for ileal bile acid transporter inhibitors supports indication-specific relief of cholestatic pruritus. Recent trials of receptor agonists show that biochemical, symptomatic, and disease-progression outcomes can diverge. Observational studies support biliary diversion in selected patients with inherited cholestasis, although comparisons among procedures and with drug treatment remain uncertain. The expanding genetic spectrum of progressive familial intrahepatic cholestasis and real-world treatment reports refine patient selection but provide limited evidence for long-term surgical outcomes. Bile metabolomics and synthesis markers remain unvalidated for timing cholecystectomy. Conclusions: Molecular findings are useful when they answer a defined diagnostic or therapeutic question. They can guide specialist treatment and surveillance alongside anatomical assessment. Prospective studies must establish whether molecular stratification improves outcomes in biliary surgical populations.